Webb Nathan D, McCanless Jonathan D, Courtney Harry S, Bumgardner Joel D, Haggard Warren O
University of Memphis, Memphis, TN, USA.
Clin Orthop Relat Res. 2008 Jun;466(6):1383-7. doi: 10.1007/s11999-008-0245-0. Epub 2008 Apr 23.
The emergence of resistant strains of Gram-positive organisms in osteomyelitis creates treatment challenges. Daptomycin is an antibiotic that shows promise for treating some resistant strains of Gram-positive infections; however, it has not been widely used clinically for the treatment of osteomyelitis. We determined whether daptomycin eluted from calcium sulfate-a local delivery vehicle used for the treatment of osteomyelitis-retained activity against Gram-positive bacteria. Daptomycin was mixed with calcium sulfate hemihydrate, with both laboratory powder and a commercial kit, to form a hardened pellet. Daptomycin was eluted from calcium sulfate and retained its ability to inhibit bacterial growth of Staphylococcus aureus and Staphylococcus epidermidis for eluates gathered up to 28 days. Our preliminary data demonstrates sterilized pellets with daptomycin retained their ability to inhibit bacterial growth of certain strains of Gram-positive organisms.
革兰氏阳性菌耐药菌株在骨髓炎中的出现给治疗带来了挑战。达托霉素是一种抗生素,对治疗某些革兰氏阳性菌耐药感染显示出前景;然而,它尚未在临床上广泛用于治疗骨髓炎。我们确定了从硫酸钙(一种用于治疗骨髓炎的局部给药载体)洗脱的达托霉素是否对革兰氏阳性菌仍保持活性。达托霉素与半水硫酸钙混合,使用实验室粉末和商业试剂盒,形成硬化小球。从硫酸钙中洗脱的达托霉素在收集长达28天的洗脱液中,仍保持抑制金黄色葡萄球菌和表皮葡萄球菌细菌生长的能力。我们的初步数据表明,含达托霉素的灭菌小球仍保持抑制某些革兰氏阳性菌菌株细菌生长的能力。